NASDAQ:CWBR CohBar (CWBR) Stock Price, News & Analysis → Don't Pay a Dime for Marc Lichtenfeld's Top AI Picks (From The Oxford Club) (Ad) Free CWBR Stock Alerts $0.78 0.00 (0.00%) (As of 06/13/2024 ET) Add Compare Share Share Today's Range$0.78▼$0.7850-Day Range$0.76▼$1.0052-Week Range$0.51▼$3.59Volume2,785 shsAverage Volume684 shsMarket Capitalization$2.27 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends Get CohBar alerts: Email Address Ad GoldenCrest MetalsBiden’s Tax Plan Could Destroy Your Retirement Savings!Leading economists are issuing stark warnings: The anticipated capital gains tax increase under President Biden could drastically undermine your retirement plans by 2025.Learn More Today About CohBar Stock (NASDAQ:CWBR)CohBar, Inc., a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases. It develops CB4211, a therapeutic that is in Phase 1a/1b clinical trial for the treatment of nonalcoholic steatohepatitis and obesity; and CB5138 Analogs, which is in preclinical study to treat idiopathic pulmonary fibrosis and other fibrotic diseases. CohBar, Inc. was incorporated in 2007 and is based in Menlo Park, California.Read More CWBR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CWBR Stock News HeadlinesApril 16, 2024 | finance.yahoo.comCohBar, Inc. (CWBR)January 23, 2024 | morningstar.comNorth American Morning Briefing: Stock Futures Steady as Earnings Season Ramps UpJanuary 19, 2024 | morningstar.comCohBar Inc CWBRJanuary 9, 2024 | morningstar.comNorth American Morning Briefing: Samsung Warning Knocks Tech StocksNovember 29, 2023 | benzinga.comCohBar Stock (NASDAQ:CWBR) Dividends: History, Yield and DatesNovember 28, 2023 | msn.comCohBar announces Nasdaq's notice of delisting; does not plan to request hearingNovember 1, 2023 | msn.comU.S. shares higher at close of trade; Dow Jones Industrial Average up 0.67%November 1, 2023 | benzinga.comWhy CohBar (CWBR) Stock Is Down Nearly 50% TodayAugust 15, 2023 | finanznachrichten.deCohBar, Inc.: CohBar Reports Second Quarter 2023 Financial ResultsAugust 14, 2023 | finance.yahoo.comCohBar Reports Second Quarter 2023 Financial ResultsJuly 17, 2023 | markets.businessinsider.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates WTT, CWBR, DMJune 29, 2023 | markets.businessinsider.comIMPORTANT ALERT: Halper Sadeh LLC Investigates PDCE, CWBR, EMAN, HMPTJune 5, 2023 | msn.comCohBar's Acquisition Partner Touts Encouraging Data From Personalized Cancer VaccineJune 3, 2023 | benzinga.comLifshitz Law PLLC Announces Investigations of CWBR, GHL, PDCE, and VECTMay 31, 2023 | benzinga.comCOHBAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of CohBar, Inc. - CWBRMay 30, 2023 | finance.yahoo.comMorphogenesis, Inc. and CohBar, Inc. Announce Acceptance of Abstract for Poster Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual MeetingMay 25, 2023 | benzinga.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating CohBar, Inc. MergerMay 24, 2023 | benzinga.comShareholder Alert: Ademi LLP investigates whether CohBar, Inc. has obtained a Fair Price in its transaction with Morphogenesis, Inc.May 24, 2023 | msn.comWhy Inovio Pharmaceuticals Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving PremarketMay 23, 2023 | msn.comCohBar Almost Quadruples amid Morphogenesis MergerMay 23, 2023 | benzinga.comCohBar Stock Doubles: Company Agrees To Merge With Morphogenesis To Advance Late-Stage Oncology CandidatesMay 23, 2023 | investorplace.comWhy Is CohBar (CWBR) Stock Up 130% Today?May 23, 2023 | marketwatch.comCohbar to Merge with Morphogenesis; Combined Company to Be Called TuHURA BiosciencesMay 23, 2023 | technews.tmcnet.comCWBR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of CohBar, Inc. Is Fair to ShareholdersMay 23, 2023 | marketwatch.comCohBar Shares Double on Morphogenesis MergerSee More Headlines Receive CWBR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CohBar and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/15/2021Today6/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:CWBR CUSIPN/A CIK1522602 Webwww.cohbar.com Phone(650) 446-7888FaxN/AEmployees9Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$5.27 per share Price / Book0.15Miscellaneous Outstanding Shares2,910,000Free Float2,718,000Market Cap$2.27 million OptionableNot Optionable Beta1.46 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesDr. Pinchas Cohen Dean (Age 67)M.D., Founder & Member of Scientific Advisory Board Comp: $65.25kDr. Nir Yacov Barzilai M.D. (Age 68)Founder & Member of Scientific Advisory Board Comp: $65.25kDr. John M. Amatruda M.D. (Age 78)Ph.D., Co-Founder Comp: $31.5kMs. Jordyn TaraziDirector of Investor RelationsKey CompetitorsNovanNASDAQ:NOVNUniverse PharmaceuticalsNYSE:UPCAeterna ZentarisNASDAQ:AEZSNuCanaNASDAQ:NCNACan-Fite BioPharmaNYSE:CANFView All CompetitorsInstitutional OwnershipRVW Wealth LLCSold 5,263,213 shares on 4/8/2024Ownership: 6.237%View All Institutional Transactions CWBR Stock Analysis - Frequently Asked Questions How have CWBR shares performed in 2024? CohBar's stock was trading at $0.74 at the beginning of the year. Since then, CWBR shares have increased by 5.4% and is now trading at $0.78. View the best growth stocks for 2024 here. How were CohBar's earnings last quarter? CohBar, Inc. (NASDAQ:CWBR) announced its earnings results on Monday, November, 15th. The company reported ($1.50) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($2.70) by $1.20. During the same quarter in the previous year, the business earned ($1.20) EPS. When did CohBar's stock split? CohBar's stock reverse split on Friday, September 23rd 2022. The 1-30 reverse split was announced on Friday, September 23rd 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, September 23rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. What other stocks do shareholders of CohBar own? Based on aggregate information from My MarketBeat watchlists, some companies that other CohBar investors own include Strongbridge Biopharma (SBBP), ZIOPHARM Oncology (ZIOP), AcelRx Pharmaceuticals (ACRX), Aptinyx (APTX), Axcella Health (AXLA), Aytu BioPharma (AYTU), Calithera Biosciences (CALA), Cidara Therapeutics (CDTX), Catalyst Pharmaceuticals (CPRX) and DURECT (DRRX). Who are CohBar's major shareholders? CohBar's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include RVW Wealth LLC (6.24%). Insiders that own company stock include Joseph J Sarret, Kenneth C Cundy and Misha Petkevich. View institutional ownership trends. How do I buy shares of CohBar? Shares of CWBR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:CWBR) was last updated on 6/14/2024 by MarketBeat.com Staff From Our PartnersHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredPresident KamalaThe sneaky (yet 100% legal) way for Obama to return to power The ONLY way Democrats can keep the White Hous...Stansberry Research | SponsoredTiny, One-Half Inch Pellet the Key to INFINITE Energy?It’s a tiny, $1 billion company that holds the key to this power. And yet, it’s the largest company of its ...Eagle Publishing | SponsoredCollect 10%+ Dividends from AI's Explosive Growth?What if I told you there was a way to collect double-digit income from the AI revolution... Without having ...The Oxford Club | SponsoredThe Single Biggest Breakthrough of the Decade Billionaires, Jeff Bezos, Bill Gates, Warren Buffett, and Sir Richard Branson are rallying behind this technol...Porter & Company | SponsoredEstee Lauder, MAC, and other beauty brands are raving about this emerging NYSE AI companyA Little-known NYSE Company is Empowering the Beauty Industry with Innovative AI and AR Tools.Financial Markets Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CohBar, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CohBar With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.